by plexusventures_h3tnl0 | Jul 14, 2026 | Uncategorized
Tokyo, Japan – Plexus Ventures is proud to celebrate the 20th anniversary of our Tokyo Office in 2026 — two decades of dedicated service to Japanese pharmaceutical, biotechnology, consumer health, and medical device companies. A Foundation Built on Experience The...
by plexusventures_h3tnl0 | Apr 17, 2024 | Uncategorized
Philadelphia, Pennsylvania – First Pharma (“First Pharma”), a private Australian pharmaceutical company operating in the consumer healthcare (“CHC”) segment, has successfully completed the sale of its business to a strategic buyer. First Pharma’s portfolio of products...
by plexusventures_h3tnl0 | May 5, 2023 | Uncategorized
Philadelphia, Pennsylvania – Phoenix Labs (“Phoenix”) has acquired a portfolio of well-established consumer health products from Sanofi Consumer Health (“Sanofi”). The portfolio includes Proctosedyl™, the leading pharmacy-only haemorrhoid treatment in Australia and a...
by plexusventures_h3tnl0 | Feb 17, 2023 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful completion of an out-licensing project conducted on behalf of its client, Elthera AG of Switzerland. Plexus Ventures served as the exclusive business development advisor to Elthera in...
Recent Comments